Health Care & Life Sciences » Biotechnology | Idera Pharmaceuticals Inc.

Idera Pharmaceuticals Inc. | Ownership

Companies that own Idera Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Baker Bros. Advisors LP
4,864,616
17.89%
-33,790,195
0.33%
07/02/2018
Geode Capital Management LLC
1,711,194
6.3%
1,527,100
0.01%
06/30/2018
BlackRock Fund Advisors
1,159,017
4.26%
109,748
0%
06/30/2018
The Vanguard Group, Inc.
956,448
3.52%
102,365
0%
06/30/2018
Fidelity Management & Research Co.
490,184
1.8%
-74,962
0%
06/30/2018
Ostrum Asset Management
429,816
1.58%
-480
0.01%
06/30/2018
Invus Public Equities Advisors LLC
343,750
1.26%
0
0.12%
06/30/2018
Millennium Management LLC
317,394
1.17%
-288,676
0%
06/30/2018
SSgA Funds Management, Inc.
302,000
1.11%
15,480
0%
06/30/2018
Northern Trust Investments, Inc.
221,969
0.82%
16,041
0%
06/30/2018

About Idera Pharmaceuticals

View Profile
Address
505 Eagleview Boulevard
Exton Pennsylvania 19341
United States
Employees -
Website http://www.iderapharma.com
Updated 07/08/2019
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The firm uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.